Low Mercury Concentration Produces Vasoconstriction, Decreases Nitric Oxide Bioavailability and Increases Oxidative Stress in Rat Conductance Artery

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Lemos, Núbia Belem ^a   Angeli, Jhuli Keli ^a   de Faria, Thaís Oliveira ^a   Ribeiro Junior, Rogério Faustino ^a   Vassallo, Dalton Valentim ^a,b   Padilha, Alessandra Simão ^a   Stefanon, Ivanita ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CYCLOOXYGENASE 2; DIPEPTIDYL CARBOXYPEPTIDASE; MERCURY; NITRIC OXIDE; PHENYLEPHRINE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RESPONSE; ENZYME ACTIVITY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR ENDOTHELIUM; VASCULAR RING; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; ARTERIES; BIOLOGICAL AVAILABILITY; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; ENDOTHELIUM, VASCULAR; FREE RADICALS; MALE; MERCURY; NADPH OXIDASE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE; OXIDATIVE STRESS; PHENYLEPHRINE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RENIN-ANGIOTENSIN SYSTEM; SUPEROXIDE DISMUTASE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

RATTUS;

EID: 84868676956     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049005     Document Type: Article

References (39)

1. Clarkson TW, Magos L, Myers GJ, (2003) The Toxicology of Mercury - Current Exposures and Clinical Manifestations. N Engl J Med 349: 1731-1737.
2. Langworth S, Sällsten G, Barregård L, Cynkier I, Lind ML, et al. (1997) Exposure to mercury vapour and impact on health in the dental profession in Sweden. Journal of Dental Research 76: 1397-1404.
3. McKelvey W, Gwynn RC, Jeffery N, Kass D, Thorpe LE, et al. (2007) A biomonitoring study of lead, cadmium, and mercury in the blood of New York city adults. Environ Health Perspect 115: 1435-1441.
4. Salonen JT, Seppänen K, Nyyssönen K, Korpela H, Kauhanen J, et al. (1995) Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern finnish men. Circulation 91: 645-655.
5. Salonen JT, Seppanen K, Lakka TA, Salonen R, Kaplan GA, (2000) Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis 148: 265-273.
6. Virtanen JK, Voutilainen S, Rissanen TH, Mursu J, Tuomainen TP, et al. (2005) Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler Thromb Vasc Biol 25: 228-233.
7. Choi AL, Weihe P, Budtz-Jørgensen E, Jørgensen PJ, Salonen JT, et al. (2009) Methylmercury exposure and adverse cardiovascular effects in faroese whaling men. Environ Health Perspect 117 (3): 367-372.
8. Pinheiro MC, Macchi BM, Vieira JL, Oikawa T, Amoras WW, et al. (2008) Mercury exposure and antioxidant defenses in women: a comparative study in the Amazon. Environ Res 107: 53-59.
9. World Health Organization (1991) Methylmercury. Apud Environmental Health Criteria, 118, Geneva. Switzerland.
10. Houston MC, (2007) The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Altern Ther Health Med 13: S128-S133.
11. Huang YL, Cheng SL, Lin TH, (1996) Lipid peroxidation in rats administrated with mercuric chloride. Biol Trace Elem Res 52: 193-206.
12. Mahboob M, Shireen KF, Atkinson A, Khan AT, (2001) Lipid peroxidation and antioxidant enzyme activity in different organs of mice exposed to low level of mercury. J Environ Sci Health B 36: 687-697.
13. Wiggers GA, Pecanha FM, Briones AM, Perez-Giron JV, Miguel M,et al. (2008) Low mercury concentrations cause oxidative stress and endothelial dysfunction in conductance and resistance arteries. Am J Physiol Heart Circ Physiol 295: H1033-H1043.
14. Wolf MB, Baynes JW, (2007) Cadmium and mercury cause an oxidative stress-induced endothelial dysfunction. Biometals 20: 73-81.
15. Eckhardt W, Bellmann K, Kolb H, (1999) Regulation of inducible nitric oxide synthase expression in beta cells by environmental factors: heavy metals. Biochem J 15: 695-700.
16. Kim SH, Sharma RP, (2004) Mercury-induced apoptosis and necrosis in murine macrophages: role of calcium-induced reactive oxygen species and p38 mitogenactivated protein kinase signaling. Toxicol Appl Pharmacol 196: 47-57.
17. Bernhoft RA (2012) Mercury toxicity and treatment: a review of the literature. J Environ and Public Health Article ID 460508.
18. Roulet M, Lucotte M, Canuel R, Rheaut I, Tran S, et al. (1998) Distribution and partition of total mercury in waters of the Tapajos River Basin, Brazilian Amazon. Sci Total Environ 213: 203-211.
19. Clarkson TW, Magos L, (2006) The toxicology of mercury and its chemical compounds. Crit Rev in Toxicol 8: 609-662.
20. Rooney JPK, (2007) The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury Toxicol. 234: 145-156.
21. Zalups RK, (2000) Molecular interactions with mercury in the kidney. Pharmacol Rev 52: 113-143.
22. Mitra S, Deshmukh A, Sachdeva R, Lu J, Mehta JL, (2011) Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci 342: 135-142.
23. Harja E, Bu DX, Hudson BI, Chang JS, Shen X, et al. (2008) Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J Clin Invest 118: 183-194.
24. Furieri LB, Galán M, Avendaño MS, García-Redondo AB, Aguado A, et al. (2011) Endothelial dysfunction of rat coronary arteries after exposure to low concentrations of mercury is dependent on reactive oxygen species. Br J Pharmacol 162(8): 1819-1831.
25. Peçanha FM, Wiggers GA, Briones AM, Perez-Giron JV, Miguel M, et al. (2010) The role of cyclooxygenase (COX)-2 derived prostanoids on vasoconstrictor responses to phenylephrine is increased by exposure to mercury concentration. J Physiol Pharmacol 61(1): 29-36.
26. Wiggers GA, Stefanon I, Padilha AS, Peçanha FM, Vassallo DV, et al. (2008) Low nanomolar concentration of mercury chloride increases vascular reactivity to phenylephrine and local angiotensin production in rats. Comp Biochem and Physiol C Toxicol Pharmacol 147: 252-260.
27. Vassallo DV, Simões MR, Furieri LB, Fioresi M, Fiorim J, et al. (2011) Toxic effects of mercury, lead and gadolinium on vascular reactivity. Braz J Med Biol Res 44(9): 939-946.
28. Vassallo DV, Moreira CM, Oliveira EM, Bertollo DM, Veloso TC, (1999) Effects of mercury on the isolated heart muscle are prevented by DTT and cysteine. Toxicol Appl Pharmacol. 15 156(2): 113-118.
29. Bjorkman L, Sandborgh-Englund G, Ekstrand J, (1997) Mercury in saliva and feces after removal of amalgam fillings. Toxicol Appl Pharmocol 144: 156-62.
30. Álvarez Y, Pérez-Girón JV, Hernanz R, Briones AM, Redondo AM, et al. (2007) Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats. Pharmacol Exp Ther 321: 381-388.
31. Beckman JS, Koppenol WH, (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424-C1437.
32. Chen C, Qu L, Li B, Xing L, Jia G, et al. (2005) Increased oxidative DNA damage, as assessed by urinary 8-hydroxy-2'-deoxyguanosine concentrations, and serum redox status in persons exposed to mercury. Clin Chem 51: 759-769.
33. Hu ZW, Kerb R, Shi XY, Wei-Lavery T, Hoffman BB, (2002) Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells. J Pharmacol Exp Ther 303: 563-573.
34. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M, (2009) Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196: 193-222.
35. Grotto D, Barcelos GM, Garcia SC, Barbosa F, (2009) Low level and sub-chronic exposure to methylmercury induces hypertension in rats: nitric oxide depletion and oxidative damage as possible mechanisms. Arch Toxicol 83: 653-62.
36. Davel AP, Wenceslau CF, Akamine EH, Xavier FE, Couto GK, et al. (2011) Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update. Braz J Med Biol Res 44: 920-32.
37. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW, (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148.
38. Wolin MS, (2000) Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol 20: 1430-42.
39. Kishimoto T, Oguri T, Tada M, (1995) Effect of methylmercury (CH3HgCl) injury on nitric oxide synthase (NOS) activity in cultured human umbilical vascular endothelial cells. Toxicology 103: 1-7.